Basic Information
Basic information for MIR646HG-228-12aa
Peptide Name MIR646HG-228-12aa
Genome Position chr20:60101186-60101221[+]
Species Human
Peptide Sequence MSEEDIIVPFPS
Peptide Length 12
Unique No (MIR646HG-202-12aa,MIR646HG-205-12aa,MIR646HG-209-12aa,MIR646HG-210-12aa,MIR646HG-219-12aa,MIR646HG-226-12aa,MIR646HG-227-12aa,MIR646HG-230-12aa,MIR646HG-232-12aa,MIR646HG-233-12aa,MIR646HG-235-12aa,MIR646HG-236-12aa,MIR646HG-239-12aa,MIR646HG-244-12aa,MIR646HG-247-12aa,MIR646HG-248-12aa,MIR646HG-249-12aa,MIR646HG-250-12aa,MIR646HG-257-12aa,MIR646HG-262-12aa,MIR646HG-263-12aa,MIR646HG-270-12aa,MIR646HG-271-12aa)
Grand Average of Hydropathicity 0.2167
Relative Molecular Mass 1561.69
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000656236;MIR646HG-228
Transcript Length 585
Coding Ability 0.0615
DNA Sequence Corresponding to Peptide ATGTCAGAGGAAGACATAATTGTGCCATTTCCTTCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :